Needham analyst Serge Belanger maintained a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report) today. The company’s shares ...

In a report released today, Joseph Stringer from Needham maintained a Buy rating on Cidara Therapeutics (CDTX – Research Report), with a price ...

Montrose Environmental Group (NYSE:MEG – Free Report) had its price target decreased by Needham & Company LLC from $39.00 to ...

Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price reduced by Needham & Company LLC from $202.00 to $183.00 in a report published on Thursday,Benzinga reports. Needham & Company LLC ...

Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the ...

Cognizant Technology Solutions (CTSH) highlighted the potential of generative artificial intelligence during its Analysts Day, but economic concerns might limit near-term growth as IT departments ...

The Zurich-based sports brand said Tuesday that co-CEO Marc Maurer will be departing the company after 12 years, turning the ...

ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at ...

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...